Pila Pharma AB (publ) (OM: PILA)
Health Care · Pharmaceuticals · SE
Skr1.56
-17.02% today · -16.3% 1Y
Pila Pharma AB (publ) (OM: PILA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $9.07M and employs 1 people.
Over the last twelve months the share price has lost 16.3%, trading between 1.02 and 2.60.
Tweenvest scores Pila Pharma AB (publ) across four factors: quality 26/100, value 51/100. Its strongest factor is value.
PILA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.07M
- Revenue (TTM)
- $122.24K
- P/E
- —
- EPS
- -0.49
- Dividend yield
- —
- Beta (5Y)
- -0.31
- 52-week high
- Skr2.60
- 52-week low
- Skr1.02
- Avg volume (3M)
- —
- Shares outstanding
- 45.68M
- Employees
- 1
- Next earnings
- —
About Pila Pharma AB (publ)
Based in Sweden, PILA PHARMA AB (publ) is a pharmaceutical firm actively engaged in clinical development. The company's principal drug, XEN-D0501, is a TRPV1 antagonist which has successfully completed two phase 2a clinical studies aimed at treating type 2 diabetes. PILA PHARMA AB (publ) was founded in 2014 and maintains its headquarters in Malmö, Sweden.
- ISIN
- SE0015988274
- Founded
- 2014
- Listed since
- Jul 15, 2021
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.70 | -0.02% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $271.19 | -0.68% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.90 | +0.16% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.90 | +0.13% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.72 | +0.51% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.99 | +0.07% |
Figures last refreshed Aug 18, 2026.